DPA-Zinc around Polyplexes Acts Like PEG to Reduce Protein Binding While Targeting Cancer Cells

Adv Healthc Mater. 2023 Aug;12(21):e2203252. doi: 10.1002/adhm.202203252. Epub 2023 May 19.

Abstract

Gene therapy holds great promise as an effective treatment for many diseases of genetic origin. Gene therapy works by employing cationic polymers, liposomes, and nanoparticles to condense DNA into polyplexes via electronic interactions. Then, a therapeutic gene is introduced into target cells, thereby restoring or changing cellular function. However, gene transfection efficiency remains low in vivo due to high protein binding, poor targeting ability, and substantial endosomal entrapment. Artificial sheaths containing PEG, anions, or zwitterions can be introduced onto the surface of gene carriers to prevent interaction with proteins; however, they reduce the cellular uptake efficacy, endosomal escape, targeting ability, thereby, lowering gene transfection. Here, it is reported that linking dipicolylamine-zinc (DPA-Zn) ions onto polyplex nanoparticles can produce a strong hydration water layer around the polyplex, mimicking the function of PEGylation to reduce protein binding while targeting cancer cells, augmenting cellular uptake and endosomal escape. The polyplexes with a strong hydration water layer on the surface can achieve a high gene transfection even in a 50% serum environment. This strategy provides a new solution for preventing protein adsorption while improving cellular uptake and endosomal escape.

Keywords: dipicolylamine-zinc; gene delivery; hydration water layers; targeting cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cations
  • DNA / metabolism
  • Gene Transfer Techniques
  • Neoplasms* / therapy
  • Polyethylene Glycols / metabolism
  • Polymers / metabolism
  • Protein Binding
  • Transfection
  • Zinc*

Substances

  • Zinc
  • Polymers
  • DNA
  • Cations
  • Polyethylene Glycols